Victory Capital Management
PRAX icon

Victory Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Victory Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.08M Buy
15,160
+1,028
+7% +$325K ﹤0.01% 1363
2026
Q1 		$4.55M Buy
14,132
+834
+6% +$258K ﹤0.01% 1361
2025
Q4 		$3.92M Buy
+13,298
New +$2.48M ﹤0.01% 1399
2024
Q1 		– Sell
-15,705
Closed -$350K – 2553
2023
Q4 		$350K Buy
15,705
+14,867
+1,774% +$268K ﹤0.01% 2085
2023
Q3 		$21.5K Buy
+838
New +$15.9K ﹤0.01% 2443

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Victory Capital Management's PRAX Position: Q2 2026 in Review

Victory Capital Management increased its Praxis Precision Medicines (PRAX) stake by 7.3% in Q2 2026, buying an estimated $325K and bringing the position to 15,160 shares worth $5.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1363.

Victory Capital Management first reported a position in PRAX in Q3 2023 and has held it in 5 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Victory Capital Management held 15,160 shares of Praxis Precision Medicines worth $5.08M as of Q2 2026.
  • Victory Capital Management bought 1,028 Praxis Precision Medicines shares in Q2 2026, an estimated $325K.
  • Praxis Precision Medicines made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1363 holding.
  • Victory Capital Management first reported a position in Praxis Precision Medicines in Q3 2023 and has held it in 5 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.